On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...

The Federal Trade Commission is accusing three companies of artificially inflating insulin list prices. We have new developments on a deadly Israeli strike in Lebanon. The Food & Drug Administration .

FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

The comparative efficacy and tolerability of oral migraine medications suggest four triptans are superior to the newer, more ...

Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...

Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...

The FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the ...

Mineralys has been on the radar for some biotech investors. Read more about MLYS' hypertension treatment, upcoming trial ...

According to Biospace.com "The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, exhibiting a growth ...

We recently published a list of 10 Best Big-Name Stocks to Buy Right ... selling on individual US-listed stocks […] A Phase 3 ...